About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 3NCT00623636

Phase 3 Study of MAP0004 in Adult Migraineurs

This is a randomized, double blind, placebo controlled, parallel group study of MAP0004 in adult migraineurs. Subjects will self administer study drug in the outpatient setting.

Lead sponsor: Allergan•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Allergan

Collaborators

MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male or female between 18 and 65 years of age.
•History of episodic, acute migraine (with or without aura) with onset prior to 50

Exclusion Criteria

•Known allergy or sensitivity or contraindication to study drugs or their formulations
•History of chronic pulmonary disease, coronary artery disease (CAD), liver disease, kidney disease, seizures, stroke, or major psychiatric condition.
•Any condition that, in the opinion of the Investigator, would make the subject unsuitable for study participation

Related studies

Mind Body Balance for Pediatric Migraine

NCT04715685 · Headache, Headache Disorders, and more

Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine

NCT07170176 · Migraine Disorders, Patent Foramen Ovale, and more

EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine.

NCT05570149 · Migraine Disorders

Tai Chi for the Prophylaxis of Episodic Migraine: the Efficacy Examination and Mechanism Exploration

NCT05690737 · Migraine Disorders

Biochemical Profiling of Migraine Patients

NCT06549270 · Migraine Disorders, Chronic Migraine, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 9, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment902

Start dateJul 2008

Last updatedJan 9, 2014

Condition

Migraine Disorders

Locations shown

Swedish Pain and Headache Clinic

Seattle, Washington

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2014Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions